| Date | Research Question / Title | Unique ID | Research Team |
|---|---|---|---|
| January 22, 2021 | What are the differences in the clinical course of COVID-19 between patients undergoing chemotherapy and otherwise healthy individuals? [Update] | EOC062201v2 RR | EOC |
| January 22, 2021 | What are the differences in the clinical course of COVID-19 between patients undergoing chemotherapy and otherwise healthy individuals? [Update] | EOC062201v2 RR Table | EOC |
| May 19, 2020 | What are the risk factors for severity and death associated with COVID-19? | EPM050901 RR | Epidemiology & Modelling |
| May 19, 2020 | Risk estimates for clinical factors predicting severity and/ or mortality associated with COVID-19 | EPM050901 RR Table | Epidemiology & Modelling |
| May 19, 2020 | What is the relationship between antibody development and viral shedding and infectiousness? [Update] | LAB041601v2 RR | Laboratory |
| April 15, 2020 | At what time in the disease timeline of COVID-19 do antibodies develop? | LAB041402 RR | Laboratory |
